| 000 | 01706 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250516194228.0 | ||
| 264 | 0 | _c20141021 | |
| 008 | 201410s 0 0 eng d | ||
| 022 | _a1556-1380 | ||
| 024 | 7 |
_a10.1097/JTO.0000000000000070 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMiller, Robert E | |
| 245 | 0 | 0 |
_aRANKL inhibition blocks osteolytic lesions and reduces skeletal tumor burden in models of non-small-cell lung cancer bone metastases. _h[electronic resource] |
| 260 |
_bJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer _cMar 2014 |
||
| 300 |
_a345-54 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnticoagulants _xpharmacology |
| 650 | 0 | 4 |
_aBone Neoplasms _xmetabolism |
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xmetabolism |
| 650 | 0 | 4 |
_aEnoxaparin _xpharmacology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung Neoplasms _xmetabolism |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Nude |
| 650 | 0 | 4 |
_aOsteolysis _xdrug therapy |
| 650 | 0 | 4 |
_aOsteoprotegerin _ximmunology |
| 650 | 0 | 4 |
_aRANK Ligand _xantagonists & inhibitors |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 | _aTumor Burden |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 700 | 1 | _aJones, Jon C | |
| 700 | 1 | _aTometsko, Mark | |
| 700 | 1 | _aBlake, Michelle L | |
| 700 | 1 | _aDougall, William C | |
| 773 | 0 |
_tJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer _gvol. 9 _gno. 3 _gp. 345-54 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/JTO.0000000000000070 _zAvailable from publisher's website |
| 999 |
_c23515760 _d23515760 |
||